1)Salvarani C, et al:Polymyalgia rheumatica and giant-cell arteritis. Lancet 372:234-245, 2008 PMID 18640460
2)Dejaco C, et al:EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 77:636-643, 2018 PMID 29358285
3)Noumegni SR, et al:Temporal artery ultrasound to diagnose giant cell arteritis;A practical guide. Ultrasound Med Biol 47:201-213, 2021 PMID 33143971
4)Dejaco C, et al:EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice;2023 update. Ann Rheum Dis 83:741-751, 2023 PMID 37550004
5)Fernández-Fernández E, et al:False positives in the ultrasound diagnosis of giant cell arteritis;Some diseases can also show the halo sign. Rheumatology(Oxford)59:2443-2447, 2020 PMID 31953951
6)Dasgupta B, et al:‘Slope sign';A feature of large vessel vasculitis? Ann Rheum Dis 78:1738, 2019 PMID 31519653
7)Maz M, et al:2021 American College of Rheumatology/vasculitis foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol 73:1349-1365, 2021 PMID 34235884
8)González-Gay MA, et al:Polymyalgia rheumatica. Lancet 390:1700-1712, 2017 PMID 28774422
9)Myklebust G, Gran JT:A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis;Clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161-1168, 1996 PMID 8948307
10)Kobayashi K, et al:Ultrasound of shoulder and knee improves the accuracy of the 2012 EULAR/ACR provisional classification criteria for polymyalgia rheumatica. Rheumatology(Oxford)61:1185-1194, 2022 PMID 34164671
11)Salvarani C, et al:Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 8:509-521, 2012 PMID 22825731
12)Dejaco C, et al:Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica;A systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica. Ann Rheum Dis 74:1808-1817, 2015 PMID 26359489
13)Spiera RF, et al;SAPHYR Investigators:Sarilumab for relapse of polymyalgia rheumatica during glucocorticoid taper. N Engl J Med 389:1263-1272, 2023 PMID 37792612